VWF and venous thromboembolism: Moreover, the half-life of von Willebrand factor in patients with blood group O is significantly shorter than in the non-O group which was shown to result in a lower risk of venous thromboembolism in patients with blood group O (Jenkins et al., 2006; Gallinaro et al., 2008).